OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Diabetes Investigation is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
High prevalence of depressive symptoms among people with pediatric‐onset and adolescent‐onset type 1 diabetes: A cross‐sectional analysis of the Diabetes Study from the Center of Tokyo Women's Medical	69
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM‐Japan study	64
Abstracts	53
	40
Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study	37
Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets	37
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J‐DREAMS database	37
Association between maternal gestational diabetes mellitus and high‐sensitivity C‐reactive protein levels in 8‐year‐old children: The Yamanashi Adjunct Study of the Japan Environment and Children’s St	36
Effect of diabetes and prediabetes on the development of disability and mortality among middle‐aged Japanese adults: A 22‐year follow up of NIPPON DATA90	33
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy‐proven diabetic kidney disease: A multicenter cohort study	32
Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post‐hoc analysis of a prospective and multicen	31
Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges	30
Impact of wound microbiology on limb preservation in patients with diabetic foot infection	29
Comparison of the effects of frequent versus conventional nutritional interventions in patients with type 2 diabetes mellitus: A randomized, controlled trial	29
Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes	29
Effect of glucagon‐like peptide‐1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta‐analysis	27
Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan	27
Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance	27
Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy	26
Can we catch the second loach employing BACE1 inhibition, even as the first one might be escaping?	26
HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019	25
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real‐world clinical practice: 36 month post‐marketing observational study	24
Effects of dipeptidyl peptidase‐4 inhibition in vivo: Dipeptidyl peptidase‐4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management	24
Circular ribonucleic acid nucleoporin 98 knockdown alleviates high glucose‐induced proliferation, fibrosis, inflammation and oxidative stress in human glomerular mesangial cells by regulating the	23
	23